REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Magister-Pharm Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: MAGISTER-PHARM Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Magister-Pharm Bt. is based in Hungary, with the head office in Szentgotthard. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on March 04, 1996. 10 (2024) employees currently work for Magister-Pharm Bt.. In 2023, the company reported a net sales revenue increase of 11.71%. Its’ total assets recorded a growth of 6.3%. Magister-Pharm Bt.’s net profit margin increased by 2.03% in 2023.

Headquarters
Rakoczi u.5.
Szentgotthard; Vas; Postal Code: 9970

Contact Details: Purchase the Magister-Pharm Bt. report to view the information.

Website: http://www.mph.t-online.hu

Basic Information
Total Employees:
Purchase the Magister-Pharm Bt. report to view the information.
Outstanding Shares:
Purchase the Magister-Pharm Bt. report to view the information.
Registered Capital:
Purchase the Magister-Pharm Bt. report to view the information.
Financial Auditors:
Purchase the Magister-Pharm Bt. report to view the information.
Incorporation Date:
March 04, 1996
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Belladonna-Pharma Bt.
Company Performance
Financial values in the chart are available after Magister-Pharm Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.71%▲
Total operating revenue
11.43%▲
Operating profit (EBIT)
53.52%▲
EBITDA
46.64%▲
Net Profit (Loss) for the Period
62.86%▲
Total assets
6.3%▲
Total equity
13.48%▲
Operating Profit Margin (ROS)
1.73%▲
Net Profit Margin
2.03%▲
Return on Equity (ROE)
9.11%▲
Quick Ratio
0.04%▲
Cash Ratio
0.04%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo